Year |
Citation |
Score |
2024 |
Jia L, Tian H, Sun S, Hao X, Wen Y. EID3 inhibits the osteogenic differentiation of periodontal ligament stem cells and mediates the signal transduction of TAZ-EID3-AKT/MTOR/ERK. Biochimica Et Biophysica Acta. Molecular Cell Research. 1871: 119662. PMID 38216090 DOI: 10.1016/j.bbamcr.2024.119662 |
0.311 |
|
2021 |
Tian H, Chen X, Zhang Y, Wang Y, Fu X, Gu W, Wen Y. Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis. Molecular Medicine Reports. 23. PMID 33786612 DOI: 10.3892/mmr.2021.12053 |
0.342 |
|
2020 |
Wang Y, Zhang Y, Feng X, Tian H, Fu X, Gu W, Wen Y. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells. Oncology Reports. PMID 33650651 DOI: 10.3892/or.2020.7909 |
0.317 |
|
2018 |
Li A, Gu K, Wang Q, Chen X, Fu X, Wang Y, Wen Y. Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway. International Journal of Molecular Medicine. PMID 30106116 DOI: 10.3892/ijmm.2018.3818 |
0.302 |
|
2018 |
Chen X, Gu W, Wang Q, Fu X, Wang Y, Xu X, Wen Y. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC. Oncotarget. 9: 668-679. PMID 29416644 DOI: 10.18632/oncotarget.23089 |
0.37 |
|
2017 |
Wen Y, Ji Y, Zhang Y, Jiang B, Tang C, Wang Q, Chen X, Jia L, Gu W, Xu X. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways. International Journal of Medical Sciences. 14: 1231-1240. PMID 29104479 DOI: 10.7150/ijms.20504 |
0.308 |
|
2016 |
Xu Y, Chen B, Zheng S, Wen Y, Xu A, Xu K, Li B, Liu C. IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells. Cellular & Molecular Biology Letters. 21: 27. PMID 28536629 DOI: 10.1186/s11658-016-0029-6 |
0.415 |
|
2016 |
Xu Y, Zheng S, Chen B, Wen Y, Zhu S. Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration. Oncotargets and Therapy. 9: 2825-2833. PMID 27274278 DOI: 10.2147/OTT.S101794 |
0.357 |
|
2015 |
Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, et al. Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell. PMID 26481148 DOI: 10.1016/J.Ccell.2015.09.008 |
0.532 |
|
2013 |
Gupta GP, Vanness K, Barlas A, Manova-Todorova KO, Wen YH, Petrini JH. The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis. Molecular Cell. 52: 353-65. PMID 24120666 DOI: 10.1016/j.molcel.2013.09.001 |
0.328 |
|
2013 |
Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, Zheng J, Dershaw DD, Morris EA. MR imaging features of triple-negative breast cancers. The Breast Journal. 19: 643-9. PMID 24015869 DOI: 10.1111/Tbj.12182 |
0.307 |
|
2013 |
Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell. 154: 1060-73. PMID 23993096 DOI: 10.1016/J.Cell.2013.07.036 |
0.312 |
|
2012 |
Wen YH, Ho A, Patil S, Akram M, Catalano J, Eaton A, Norton L, Benezra R, Brogi E. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast Cancer Research and Treatment. 135: 93-102. PMID 22538771 DOI: 10.1007/S10549-012-2070-0 |
0.313 |
|
2011 |
D'Arcy C, Wen YH, Stadler ZK, Brogi E, Shia J. Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply? The American Journal of Surgical Pathology. 35: 1743-8. PMID 21997695 DOI: 10.1097/PAS.0b013e3182320cff |
0.316 |
|
2007 |
Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O. Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncology Reports. 18: 1387-93. PMID 17982621 |
0.304 |
|
2005 |
Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, Yagita H, Spohn B, Hung MC. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. Molecular Cancer Research : McR. 3: 219-26. PMID 15831675 DOI: 10.1158/1541-7786.Mcr-04-0084 |
0.698 |
|
2005 |
Cha TL, Qiu L, Chen CT, Wen Y, Hung MC. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research. 65: 2287-95. PMID 15781642 DOI: 10.1158/0008-5472.Can-04-3250 |
0.648 |
|
2004 |
Deng J, Xia W, Miller SA, Wen Y, Wang HY, Hung MC. Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway. Molecular Carcinogenesis. 39: 139-46. PMID 14991743 DOI: 10.1002/Mc.10169 |
0.442 |
|
2004 |
Yan DH, Wen Y, Su LK, Xia W, Wang SC, Zhang S, Gan L, Lee DF, Spohn B, Frey JA, Hortobagyi GN, Hung MC. A delayed chemically induced tumorigenesis in Brca2 mutant mice. Oncogene. 23: 1896-901. PMID 14981540 DOI: 10.1038/sj.onc.1207314 |
0.694 |
|
2003 |
Li YM, Wen Y, Zhou BP, Kuo HP, Ding Q, Hung MC. Enhancement of Bik antitumor effect by Bik mutants. Cancer Research. 63: 7630-3. PMID 14633680 |
0.692 |
|
2003 |
Wen Y, Giri D, Yan DH, Spohn B, Zinner RG, Xia W, Thompson TC, Matusik RJ, Hung MC. Prostate-specific antitumor activity by probasin promoter-directed p202 expression. Molecular Carcinogenesis. 37: 130-7. PMID 12884364 DOI: 10.1002/Mc.10129 |
0.547 |
|
2003 |
Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K. P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochemical and Biophysical Research Communications. 303: 219-22. PMID 12646190 |
0.403 |
|
2002 |
Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY, Hung MC. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell. 2: 323-34. PMID 12398896 DOI: 10.1016/S1535-6108(02)00154-X |
0.487 |
|
2002 |
Ding Y, Wen Y, Spohn B, Wang L, Xia W, Kwong KY, Shao R, Li Z, Hortobagyi GN, Hung MC, Yan DH. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 3290-7. PMID 12374701 |
0.479 |
|
2002 |
Lee WP, Wen Y, Varnum B, Hung MC. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis. Oncogene. 21: 329-36. PMID 11821945 DOI: 10.1038/sj.onc.1205066 |
0.655 |
|
2002 |
Zou Y, Peng H, Zhou B, Wen Y, Wang SC, Tsai EM, Hung MC. Systemic tumor suppression by the proapoptotic gene bik. Cancer Research. 62: 8-12. PMID 11782349 |
0.525 |
|
2001 |
Wen Y, Yan DH, Wang B, Spohn B, Ding Y, Shao R, Zou Y, Xie K, Hung MC. p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models. Cancer Research. 61: 7142-7. PMID 11585747 |
0.519 |
|
2001 |
Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biology. 3: 802-8. PMID 11533659 DOI: 10.1038/Ncb0901-802 |
0.444 |
|
2000 |
Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, Hung MC. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Research. 60: 6841-5. PMID 11156376 |
0.509 |
|
2000 |
Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 97: 4262-6. PMID 10759547 DOI: 10.1073/Pnas.060025397 |
0.535 |
|
2000 |
Wen Y, Yan DH, Spohn B, Deng J, Lin SY, Hung MC. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells. Cancer Research. 60: 42-6. PMID 10646849 |
0.56 |
|
1999 |
Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU, Hung MC. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene. 18: 807-11. PMID 9989832 DOI: 10.1038/Sj.Onc.1202369 |
0.575 |
|
Show low-probability matches. |